Original Article
RNA virus classified as the single member of the genus Orthohepevirus. It consists of a single serotype and four major genotypes. Genotypes 1 and 2 are responsible for human infections and are mainly distributed in developing countries. Genotypes 3 and 4 cause zoonosis with swine as the principle reservoir. HEV infection can lead to more severe, acute liver disease in pregnant women and may sometimes progress to fulminant hepatic failure. [7] It also leads to severe complications which may result in fetal and/or maternal mortality, abortion, premature delivery or perinatal death. [8, 9] The risk factors for HEV infection are related to the resistance of HEV to environmental conditions and poor sanitation in many parts of the world. [10] Following an incubation period of 2-6 weeks, an initial IgM response is followed by longer-lasting IgG antibodies. The presence of IgM anti-HEV is a marker of acute infection, and a 4-fold rise in titre of IgG anti-HEV between paired acute and convalescence sera can indicate recent HEV infection. [11] The current trend shows an increase in the prevalence of HAV and HEV infections along with an increase in the rate of HAV-HEV co-infection. There are limited data on the incidence of HEV infection and disease worldwide.
The present study aimed to determine the prevalence of HAV and HEV infections in patients with acute viral hepatitis (AVH), the rate of HAV-HEV co-infection, the prevalence of HEV infection amongst pregnant women with hepatitis and to correlate biochemical and immunological findings.
SuBjectS and MethOdS
It was a retrospective observational study conducted over 3 years from January 2015 to December 2017 after approval from the institutional ethics committee. The study population included 675 patients (out-door and hospitalised) between 3 and 70 years of age having clinical features of hepatitis such as fatigue, anorexia, nausea, vomiting, jaundice and elevated liver enzymes. After obtaining informed consent, 5 mL of blood was collected from each patient, centrifuged and serum stored at −20°C till analysis. All samples were tested in duplicate for IgM anti-HAV and IgM anti-HEV antibodies using commercially available enzyme-linked immunosorbent assay (ELISA) kits (RecombiLISA HAV IgM ELISA Test, CTK Biotech and RecombiLISA HEV IgM ELISA Test, CTK Biotech). Each serum sample was also tested for HBsAg and IgG anti-hepatitis C virus (HCV) antibodies by ELISA (using Merilisa HBsAg and Merilisa HCV kits, Meril Diagnostics Pvt., Ltd.) to rule out hepatitis B (HBV) and HCV infections.
Biochemical parameters such as liver function tests comprising of total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels were also determined.
The data collected was analysed using SPSS version 11.0 for windows (SPSS, Inc., Chicago, IL, USA). Chi-square test was used for analysing qualitative variables.
reSultS
A total of 675 serum samples from clinically suspected cases of AVH were received over 3 years from January 2015 to December 2017. Of 675 specimens, 47 (6.96%) were positive for IgM anti-HAV antibodies, 65 (9.63%) were positive for IgM anti-HEV antibodies and 14 (2.07%) patients were positive for both IgM anti-HAV and IgM anti-HEV antibodies indicating HAV-HEV co-infection [ Table 1 ]. All the patients were tested negative for HBV and HCV infections.
The prevalence of HAV infection in males and females was 7.3% and 6.7%, respectively. The prevalence of HEV infection was 8.8% in males and 10.2% in females. Prevalence of HAV-HEV co-infection was 2.6% in males and 1.7% in females. However, such differences in the prevalence rates of HAV, HEV and HAV-HEV co-infection between males and females were of no statistical significance [ Table 1 ].
The prevalence of HAV, HEV and co-infection in pregnant women with hepatitis was 5.05%, 9.4% and 1.2%, respectively [ Table 2 ].
In HAV-positive patients, total serum bilirubin, AST, ALT and ALP levels were elevated in 68.1%, 61.7%, 59.6% and 74.5% cases, respectively. In HEV-positive patients, total bilirubin, AST, ALT and ALP levels were elevated in 78.5%, 72.3%, 61.5% and 70.8% cases, respectively [ Table 3 ]. In HAV-HEV co-infection, ALP level was raised in all patients while total bilirubin, AST and ALT levels were raised in 85.7%, 64.3% and 85.7% cases, respectively.
HAV and HEV infections were prevalent all-round the year with maximum number of cases seen from May to September, that is, during summer and rainy seasons [ Figures 1 and 2 ].
diScuSSiOn
The global public health impact of enterically transmitted viral hepatitis is immense. Majority of HAV and HEV outbreaks can be explained by the lack of proper sewage disposal and sanitation system and open-air defecation which can contaminate drinking water sources. Hepatitis A infection during childhood is often asymptomatic and generally confers lifelong immunity. With improvement in socioeconomic conditions and living standards of people, the age of acquiring HAV infection is shifting from early childhood to adolescence and young adulthood. Such epidemiological shift leads to an increased incidence of symptomatic HAV infection, including increased risk of hepatic failure.
In the present study, serum samples from 675 patients clinically diagnosed with AVH were tested. Of these, 18.7% (126 cases) had positive markers for AVH which was comparatively lower than that reported in similar studies by Radhakrishnan et al. [12] (31.5%) and Joon et al. [13] (29.9%) from South India. Such discordance could be attributed to improved living standards, sanitation and environmental hygiene in our study region, differences in the study population, under-reporting and reluctance of patients in seeking medical advice.
Globally, HAV is considered as the most common cause of viral hepatitis. In India, HEV is responsible for 50%-70% of all cases of sporadic AVH. [14] In the present study, HEV (9.63%) was identified as the major cause of AVH and more common than HAV (6.96%) which is in concordance with other studies from different parts of the country. [12, 15, 16] This may be due to the high prevalence of anti-HAV antibodies in general population and improved living standards and environmental hygiene. [1] The results also highlight the doubtful protection from anti-HEV antibodies, gradual decline in protective titre of the antibody or infection from divergent strains of HEV. Several studies from India and abroad have reported a varying prevalence ranging from 1.7% to 67% for HAV and 12.6% to 78.6% for HEV. [17] [18] [19] [20] Such wide variation in positivity could be due to differences in the study population, standards of hygiene and sanitation and type of samples-whether sporadic or from outbreaks. Variation may also occur with manufacturer's lot of the diagnostic testing kits. Furthermore, antibodies to different epitopes may vary in persistence. [21] The test may perform differently in endemic and non-endemic settings as 33%-40% of general population has been found to be IgG anti-HEV positive, so there may be difficulty in distinguishing present from the past HEV infection. [22] However, in the present study, the detection of only IgM antibodies was performed in AVH cases.
The prevalence of HAV infection in the present study was 7.3% in males and 6.7% in females. However, this difference was not statistically significant. A surveillance report in the United States (Department of Health, NYSDOH BCDC Surveillance Unit) mentioned a higher prevalence of HAV infection in males as compared to females. A male preponderance of HAV infection was also observed by Kamal et al. [23] in a survey of acute hepatitis from 2001 to 2004 in Egypt and by Al-Naaimi [24] in a similar cross-sectional study in Iraq (2012). A possible explanation for this male preponderance is greater exposure of males due to their professional and social activities. However, Kuntz and Kuntz reported that men and women are subject to the same frequency of infection, irrespective of age, race and seasonal or regional factors. [25] In our study, the prevalence of HEV infection was 8.8% in males and 10.2% in females but this difference was not statistically significant. However, similar studies by Joon et al., [13] Kamal et al. [23] and Al-Naaimi et al. [24] observed a higher prevalence of HEV infection in males as compared to females. However, Nikfar et al. in a study on seroprevalence of HEV infection in children in Iran, reported that no clear gender predilection exists for hepatitis E infection. [26] Co-infection with HAV and HEV does not affect the prognosis of the patient much as these cases usually resolve with conservative treatment but in rare cases may lead to acute liver failure or hepatic encephalopathy. [13] The prevalence of HAV-HEV co-infection in the present study was 2.07% which is similar to that reported by Das et al. [27] from North-East India and Mittal et al. [28] from Rajasthan. Prevalence of co-infection was 2.6% in males and 1.7% in females, but this difference was not statistically significant.
HEV infection is one of the predominant causes of pregnancy-related complications in the developing countries. [28] Hepatitis E infection during pregnancy is associated with high rates of spontaneous abortion, preterm labour and intrauterine deaths. Mortality rates among pregnant women, especially those infected in the third trimester, ranges between 5% and 25%, which is much higher than men and non-pregnant women. [29] Studies conducted by Yuel and Kaur [30] and Patra et al. [31] showed a higher prevalence of HEV infection in pregnant women. This may be due to the fact that immunologic changes during pregnancy promote the maintenance of the foetus in the maternal environment by suppression of T-cell-mediated immunity, rendering pregnant women more susceptible to viral infections like HEV infection. During pregnancy, levels of progesterone, oestrogen and human chorionic gonadotropin increase as pregnancy advances. These hormones play a significant role in altering the immune response and promoting viral replication. [4] In the present study, the prevalence of HEV infection amongst pregnant women with hepatitis was 9.4% while in non-pregnant women, it was 11.4% [ Table 2 ]. However, no statistical significance was observed between pregnancy and HEV infection.
In our study, total serum bilirubin (normal range: 0.2-1.2 mg/dL), AST (normal range: 10-40 U/L), ALT (normal range: 7-56 U/L) and ALP (normal range: 20-140 IU/L) levels were raised in 68.1%, 61.7%, 59.6% and 74.5% of the HAV-positive patients and in 78.5%, 72.3%, 61.5% and 70.8% of the HEV-positive patients, respectively. In HAV-HEV co-infection, it was observed that ALP level was raised in all patients while total bilirubin, AST and ALT levels were raised in 85.7%, 64.3% and 85.7% cases, respectively [ Table 3 ]. Three patients with co-infection had very high levels of liver enzymes (AST and ALT >2000 IU/L). This suggests that dual infection with HAV and HEV can lead to severe disease manifestations such as acute liver failure and hepatic encephalopathy. Studies by Mittal et al. [28] and Park et al. [32] also support this observation. Furthermore, due to lack of awareness many patients present late at health-care facility as in early infection bilirubin level is usually not raised, but liver enzymes are increased. Therefore, early diagnosis with identification of the causative agent and prompt supportive care can reduce morbidity, mortality and prevent the development of complications.
It was observed in our study that HAV and HEV infections occurred throughout the year, although seasonal variation in incidence was evident with maximum number of cases reported from May to September, that is, during summer and rainy seasons. Similar findings were reported by Mittal et al. [28] and Singh et al. [33] Kumar et al. in Viral Hepatitis Surveillance-India (2011-2013) observed a 17% increase in the total number of reported hepatitis cases during June to September and laboratory-confirmed HAV cases followed the same seasonal trend with an average increase of 18%. [34] As HAV and HEV infections are transmitted by faeco-oral route, shortage of drinking water supply in summer and cross-contamination of drinking water with sewage during monsoons lead to more chances of acquiring these infections.
cOncluSiOnS
A higher seroprevalence of HEV as compared to HAV together with a co-infection rate of 2.07% in this region mandates the screening for HEV in all suspected cases of acute hepatitis. This will especially be useful in pregnant women in whom the outcomes of HEV infection are very poor. With similar faeco-oral mode of transmission of HAV and HEV, periodic surveillance of exposure pattern may be of immense public health importance. The public health sectors need to work in collaboration to increase public awareness, facilitate timely preparation and make necessary arrangements to counter outbreaks or epidemics and thus reduce morbidity, mortality and economic burden.
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